bf/NASDAQ:RGNX_icon.jpeg

COM:REGENXBIO

REGENXBIO

  • Stock

USD

Last Close

9.18

22/11 21:00

Market Cap

529.01M

Beta: -

Volume Today

684.38K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
6.09M
-
6.12M
0.54%
7.59M
23.99%
4.59M
39.52%
10.39M
126.48%
218.50M
2,002.42%
35.23M
83.88%
154.57M
338.70%
470.35M
204.30%
112.72M
76.03%
90.24M
19.94%
cost of revenue
324K
-
1.01M
210.80%
1.50M
49.26%
959K
36.19%
1.71M
78.21%
9.64M
464.07%
8.24M
14.51%
35.71M
333.37%
51.83M
45.13%
54.55M
5.23%
54.53M
0.02%
gross profit
5.76M
-
5.11M
11.28%
6.08M
19.01%
3.63M
40.35%
8.68M
139.23%
208.87M
2,305.17%
26.99M
87.08%
118.85M
340.33%
418.51M
252.13%
58.18M
86.10%
35.71M
38.62%
selling and marketing expenses
general and administrative expenses
5.47M
-
3.85M
29.65%
11.91M
209.32%
23.59M
98.04%
27.23M
15.43%
36.85M
35.33%
51.81M
40.61%
63.82M
23.16%
79.33M
24.31%
85.28M
7.50%
88.49M
3.77%
selling general and administrative expenses
5.47M
-
3.85M
29.65%
11.91M
209.32%
23.59M
98.04%
27.23M
15.43%
36.85M
35.33%
51.81M
40.61%
63.82M
23.16%
79.33M
24.31%
85.28M
7.50%
88.49M
3.77%
research and development expenses
5.05M
-
4.96M
1.78%
17.28M
248.30%
45.48M
163.22%
57.22M
25.82%
83.87M
46.57%
124.19M
48.06%
166.29M
33.91%
181.44M
9.11%
242.45M
33.63%
214.95M
11.35%
other expenses
-47K
-
-26K
44.68%
-102K
292.31%
116K
213.73%
42K
63.79%
-10K
123.81%
7.97M
79,850%
-2.24M
128.04%
-6.68M
198.70%
-397K
94.06%
cost and expenses
10.85M
-
9.77M
9.93%
30.67M
213.84%
69.93M
128.02%
86.28M
23.38%
130.41M
51.15%
184.23M
41.28%
273.80M
48.62%
310.37M
13.36%
375.60M
21.02%
358.37M
4.59%
operating expenses
10.53M
-
8.77M
16.72%
29.16M
232.74%
68.97M
136.48%
84.57M
22.62%
120.77M
42.80%
175.99M
45.73%
238.09M
35.28%
258.53M
8.59%
321.06M
24.18%
303.84M
5.36%
interest expense
611K
-
321K
47.46%
20K
93.77%
771K
-
26.28M
3,308.17%
23.25M
11.50%
6.86M
70.49%
ebitda
-4.76M
-
-3.65M
23.31%
-23.08M
531.98%
-65.34M
183.10%
-78.60M
20.30%
81.03M
203.09%
-197.56M
343.81%
-114.96M
41.81%
160.70M
239.78%
-262.53M
263.37%
-250.81M
4.47%
operating income
-4.78M
-
-3.68M
22.91%
-23.14M
528.38%
-65.34M
182.40%
-75.89M
16.14%
88.10M
216.10%
-149.00M
269.12%
-119.23M
19.98%
159.98M
234.17%
-262.88M
264.32%
-268.13M
2.00%
depreciation and amortization
14K
-
30K
114.29%
80K
166.67%
544K
580%
2.69M
393.75%
3.98M
48.25%
-48.56M
1,319.46%
4.27M
108.80%
719K
83.17%
342K
52.43%
17.32M
4,964.33%
total other income expenses net
-14K
-
-30K
114.29%
289K
1,063.33%
1.94M
570.59%
2.72M
40.14%
7.07M
160.31%
51.51M
628.57%
13.22M
74.33%
-18.73M
241.67%
-17.53M
6.43%
4.48M
125.57%
income before tax
-5.39M
-
-4.00M
25.69%
-22.81M
469.85%
-63.40M
177.94%
-73.17M
15.40%
104.12M
242.30%
-97.49M
193.63%
-106.01M
8.74%
141.25M
233.24%
-280.40M
298.52%
-263.65M
5.98%
income tax expense
597K
-
291K
51.26%
-60K
120.62%
-435K
625%
686K
257.70%
4.18M
509.18%
-2.75M
165.92%
5.24M
290.20%
13.41M
155.86%
-84K
100.63%
-152K
80.95%
net income
-5.39M
-
-4.00M
25.69%
-22.81M
469.85%
-62.97M
176.04%
-73.17M
16.20%
99.94M
236.58%
-94.73M
194.79%
-111.25M
17.44%
127.84M
214.91%
-280.32M
319.27%
-263.49M
6.00%
weighted average shs out
13.15M
-
13.15M
0%
9.17M
30.24%
26.41M
187.90%
29.88M
13.14%
33.43M
11.88%
36.69M
9.76%
37.28M
1.61%
42.44M
13.83%
43.15M
1.68%
43.73M
1.35%
weighted average shs out dil
13.15M
-
13.15M
0%
9.17M
30.24%
26.41M
187.90%
29.88M
13.14%
36.65M
22.66%
36.69M
0.11%
37.28M
1.61%
43.91M
17.79%
43.15M
1.73%
43.73M
1.35%
eps
-0.41
-
-0.30
26.83%
-2.49
730.00%
-2.38
4.42%
-2.45
2.94%
2.99
222.04%
-2.58
186.29%
-2.98
15.50%
3.01
201.01%
-6.50
315.95%
-6.02
7.38%
epsdiluted
-0.41
-
-0.30
26.83%
-2.49
730.00%
-2.38
4.42%
-2.45
2.94%
2.73
211.43%
-2.58
194.51%
-2.98
15.50%
2.91
197.65%
-6.50
323.37%
-6.02
7.38%

All numbers in USD (except ratios and percentages)